Sign Up

SKYE

COM:SKYEBIOSCIENCE

Skye Bioscience

  • Stock

Last Close

4.17

22/11 21:00

Market Cap

124.99M

Beta: -

Volume Today

117.86K

Avg: -

OverviewAnalysisMetricsFinancialsFilingspeopleAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
2.33
-
cash conversion cycle
57.40
-
cash per share
0.01
-
0.02
199.94%
0.19
844.02%
0.00
98.20%
0.01
172.29%
0.02
64.22%
0.01
11.49%
0.01
20.96%
0.02
106.44%
0.00
89.86%
1.48
65,727.52%
company equity multiplier
-0.80
-
-0.77
3.98%
7.45
1,070.58%
-0.22
102.99%
-0.70
212.49%
-0.13
81.94%
3.64
2,997.00%
5.93
62.68%
1.68
71.64%
-3.03
280.23%
-5.60
84.92%
days of inventory outstanding
36.18
-
days of payables outstanding
5.98
-
3.40K
-
days of sales outstanding
27.21
-
dividend yield
ebit per revenue
-0.35
-
ebt per ebit
0.03
-
1
3,083.58%
1.12
12.10%
0.71
36.62%
0.80
12.79%
4.09
410.38%
-0.16
103.88%
1.04
756.66%
1.09
4.10%
1.06
2.04%
2.75
158.88%
effective tax rate
0.91
-
-0.00
100.10%
-0.00
61.33%
-0.00
42.05%
-0.00
2.71%
-0.00
83.46%
0.00
1,875.32%
-0.00
116.06%
-0.00
1.04%
-0.00
40.43%
-0.00
72.37%
enterprise value multiple
-161.33K
-
-7.30K
95.47%
-618.32
91.54%
-246.70
60.10%
-282.90
14.67%
-2.51K
786.98%
-663.56
73.56%
-366.86
44.71%
-675.47
84.12%
-186.02
72.46%
-0.98
99.47%
fixed asset turnover
8.59
-
free cash flow per share
-0.01
-
-0.17
2,010.78%
-0.22
27.43%
-0.19
14.58%
-0.12
36.79%
-0.03
72.60%
-0.04
36.89%
-0.03
41.10%
-0.02
38.53%
-0.02
42.44%
-1.99
8,565.64%
gross profit margin
0.61
-
interest coverage
-55.98
-
-8.27
-
3.45
141.80%
-5.79K
167,584.38%
-49.52
99.14%
-6.71
86.44%
-8.90
32.60%
-10.22
14.85%
-27.53
169.25%
-15.09
45.20%
inventory turnover
10.09
-
long term debt to capitalization
-0.10
-
0.41
531.92%
0.76
83.80%
0.01
98.26%
-0.09
-
net income per ebt
31.84
-
1.00
96.86%
1.00
0.06%
1.00
0.01%
1.00
0.00%
1.00
0.04%
1.00
0.16%
1.00
0.18%
1.00
0.00%
1.00
0.01%
1.00
0.03%
net profit margin
-0.35
-
operating cash flow per share
-0.00
-
-0.17
9,041.94%
-0.22
29.05%
-0.19
14.80%
-0.12
36.97%
-0.03
72.46%
-0.04
37.04%
-0.03
41.17%
-0.02
39.31%
-0.02
44.12%
-1.99
8,576.92%
operating cycle
63.39
-
operating profit margin
-0.35
-
payables turnover
61.00
-
0.11
-
pretax profit margin
-0.01
-
price fair value
-106.64K
-
-43.97K
58.77%
6.29K
114.31%
-985.96
115.67%
-1.33K
34.43%
-778.51
41.26%
8.05K
1,133.61%
5.12K
36.39%
901.37
82.39%
-747.61
182.94%
-8.94
98.80%
receivables turnover
13.42
-
return on assets
-0.83
-
-7.85
849.77%
-1.38
82.43%
-9.83
612.79%
-5.55
43.50%
-9.81
76.61%
0.53
105.37%
-2.46
566.16%
-0.86
64.78%
-2.14
147.27%
-3.15
47.45%
return on capital employed
3.30
-
6.03
82.70%
-1.47
124.43%
13.20
995.85%
15.51
17.50%
0.34
97.84%
-6.46
2,026.30%
-3.34
48.38%
-1.32
60.43%
6.09
561.00%
6.97
14.55%
return on equity
0.66
-
6.03
812.01%
-10.28
270.50%
2.19
121.31%
3.87
76.56%
1.23
68.11%
1.92
55.60%
-14.55
858.34%
-1.45
90.01%
6.48
545.65%
17.66
172.66%
total debt to capitalization
-0.35
-
-0.42
-
-0.10
76.96%
0.41
531.92%
0.77
85.70%
0.27
65.27%
-1.78
767.70%
1.86
204.25%

All numbers in (except ratios and percentages)